SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-008866
Filing Date
2015-01-13
Accepted
2015-01-13 09:08:34
Documents
4
Period of Report
2015-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850076d8k.htm 8-K 17731
2 EX-10.42 d850076dex1042.htm EX-10.42 124114
3 EX-99.1 d850076dex991.htm EX-99.1 10365
4 GRAPHIC g850076ex99_1pg001.jpg GRAPHIC 7583
  Complete submission text file 0001193125-15-008866.txt   164241
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 15523700
SIC: 2834 Pharmaceutical Preparations